首 页
医药产品
医保药品
中标目录
医药招标
数据中心
医学资料
医药新闻
医药展会
OTC药品
保健品
医疗器械
处方药
专科药
中医药
器械中标目录
药品批发行情
求购信息
医药下载
药价简讯
当前位置:药药网 / 药品 / 美国NDC未完成药物数据库文件(本栏目更新到2026-3-31)
药品名称:
商品名称:
药品NDC:
上市日期:
-
格式:2020-5-3
注册申请号:
市场分类:
不限
ANDA
BLA
NDA
EMERGENCY USE AUTHORIZATION
NDA AUTHORIZED GENERIC
OTC MONOGRAPH FINAL
OTC MONOGRAPH NOT FINAL
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
UNAPPROVED DRUG OTHER
UNAPPROVED HOMEOPATHIC
UNAPPROVED MEDICAL GAS
活性成分:
持证企业:
美国药品NDC(国家药品编码)与药品说明书数据库
美国NDC未完成药物数据库文件
美国NDC复合药物数据库文件
美国NDC数据库排除药物数据库文件
 美国NDC未完成药物数据库文件21130条(本栏目更新到2026-3-31)
药品名称(分析)
商品名
药品NDC
专利人(分析)
上市日期
活性成分
市场分类
规格(分析)
申请号
vilazodone hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1121
Allergan, Inc.
20110429
VILAZODONE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
20
0456-1121_760691a3-e2c6-46fb-b596-ab19b331ec4d
vilazodone hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1141
Allergan, Inc.
20110429
VILAZODONE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
40
0456-1141_760691a3-e2c6-46fb-b596-ab19b331ec4d
linaclotide
DRUG FOR FURTHER PROCESSING
0456-1204
Allergan, Inc.
20120908
LINACLOTIDE
DRUG FOR FURTHER PROCESSING
145
0456-1204_88374680-8113-4864-80e0-1e050726b1e4
linaclotide
DRUG FOR FURTHER PROCESSING
0456-1205
Allergan, Inc.
20120908
LINACLOTIDE
DRUG FOR FURTHER PROCESSING
290
0456-1205_88374680-8113-4864-80e0-1e050726b1e4
linaclotide
DRUG FOR FURTHER PROCESSING
0456-1206
Allergan, Inc.
20170130
LINACLOTIDE
DRUG FOR FURTHER PROCESSING
72
0456-1206_88374680-8113-4864-80e0-1e050726b1e4
memantine hydrochloride and donepezil hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1208
Allergan, Inc.
20160718
DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
10; 7
0456-1208_ce239dd3-32d7-45bf-b314-8c66271fea30
memantine hydrochloride and donepezil hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1215
Allergan, Inc.
20141224
DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
10; 14
0456-1215_ce239dd3-32d7-45bf-b314-8c66271fea30
memantine hydrochloride and donepezil hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1222
Allergan, Inc.
20160718
DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
10; 21
0456-1222_ce239dd3-32d7-45bf-b314-8c66271fea30
memantine hydrochloride and donepezil hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1238
Allergan, Inc.
20141224
DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
10; 28
0456-1238_ce239dd3-32d7-45bf-b314-8c66271fea30
nebivolol hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1403
Allergan, Inc.
20080122
NEBIVOLOL HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
2.5
0456-1403_17f4d61c-b7f2-4839-b3f6-b386b0ca131e
nebivolol hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1406
Allergan, Inc.
20080122
NEBIVOLOL HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
5
0456-1406_17f4d61c-b7f2-4839-b3f6-b386b0ca131e
nebivolol hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1411
Allergan, Inc.
20080122
NEBIVOLOL HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
10
0456-1411_17f4d61c-b7f2-4839-b3f6-b386b0ca131e
nebivolol hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1421
Allergan, Inc.
20080122
NEBIVOLOL HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
20
0456-1421_17f4d61c-b7f2-4839-b3f6-b386b0ca131e
milnacipran hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1511
Allergan, Inc.
20090417
MILNACIPRAN HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
100
0456-1511_771c9d98-b4eb-4dd3-9b2b-64eaf6a2310e
milnacipran hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1513
Allergan, Inc.
20090417
MILNACIPRAN HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
12.5
0456-1513_771c9d98-b4eb-4dd3-9b2b-64eaf6a2310e
milnacipran hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1526
Allergan, Inc.
20090417
MILNACIPRAN HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
25
0456-1526_771c9d98-b4eb-4dd3-9b2b-64eaf6a2310e
milnacipran hydrochloride
DRUG FOR FURTHER PROCESSING
0456-1551
Allergan, Inc.
20090417
MILNACIPRAN HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
50
0456-1551_771c9d98-b4eb-4dd3-9b2b-64eaf6a2310e
ESCITALOPRAM OXALATE
DRUG FOR FURTHER PROCESSING
0456-2006
Allergan, Inc.
20020814
ESCITALOPRAM OXALATE
DRUG FOR FURTHER PROCESSING
5
0456-2006_1bf48cea-44ee-484a-a03c-e397b758409b
ESCITALOPRAM OXALATE
DRUG FOR FURTHER PROCESSING
0456-2011
Allergan, Inc.
20020814
ESCITALOPRAM OXALATE
DRUG FOR FURTHER PROCESSING
10
0456-2011_1bf48cea-44ee-484a-a03c-e397b758409b
ESCITALOPRAM OXALATE
DRUG FOR FURTHER PROCESSING
0456-2021
Allergan, Inc.
20020814
ESCITALOPRAM OXALATE
DRUG FOR FURTHER PROCESSING
20
0456-2021_1bf48cea-44ee-484a-a03c-e397b758409b
首页
(current)
23
(current)
24
(current)
25
(current)
26
(current)
27
(current)
28
(current)
29
(current)
30
(current)
31
(current)
32
(current)
(current)
末页
(current)
网站地图
-
网站开发
-
网站简介
-
会员服务
-
法律声明
-
联系我们
-
药品招商频道
-
药品信息排行
-
2018年版国家基本药物目录
-
意见反馈
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:
医药研究数据
|
医药资料
|
SDA药品评审中心
|
中医网
|
中药处方系统
|
爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究 客服热线:0575-83552251 / 13754370441 QQ客服:
浙ICP备16010490号-2
增值电信业务经营许可证:
浙B2-20220931
互联网药品信息服务资格证书编号:
(浙)-经营性2023-0215
浙公网安备:330683240604819103159
医药代理商群1:
医药代理商群2:
医药代理商群3: